Search
Search Results
##search.searchResults.foundPlural##
-
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1412PDF: 497HTML: 236 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2527PDF: 722HTML: 194 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2703PDF: 928HTML: 3100flowcytometric result of peripheral blood sample: 155 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2393PDF: 755HTML: 1719 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2689PDF: 1065HTML: 3252 -
Pseudo-differentiation syndrome
1275PDF: 631HTML: 10828Figure 1: peripheral blood showing myeloblasts with auer rods: 105Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 93Figure 3: CXR showing pulmonary infiltartes with consolidation: 115Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 92Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 108 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2721PDF: 814HTML: 6493Untitled: 204Untitled: 167Untitled: 163Untitled: 186 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2668PDF: 1732HTML: 3624Pellagatti Fig 1: 182Pellagatti Fig. 2: 182 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1669PDF: 921HTML: 126 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
896PDF: 482HTML: 169 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1808PDF: 867HTML: 1738Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 142 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1515PDF: 772HTML: 136 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1130PDF: 706HTML: 1327Figure 1: 153Figure 2: 150 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
658PDF: 782PDF Supp. Files: 68HTML: 169 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1924PDF: 731HTML: 3098 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3458PDF: 1440HTML: 4272CoverLetter: 167Figure1: 174 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1770PDF: 874HTML: 930Referring article: 715 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1123PDF: 678Html: 77 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13171PDF: 928HTML: 7269







